Gengos Andrew
Terns Pharmaceuticals, Inc. · Chief Financial Officer
Gengos Andrew is listed in public filings as officer: Chief Financial Officer. This Gengos Andrew insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Terns Pharmaceuticals, Inc. (TERN), and LeonaBio, Inc. (LONA). Investors use Gengos Andrew's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0137.5k shares | OtherMay 5, 2026 | $5.1M137.5k shares | $37.18 | -- | |
| $068.8k shares | OtherMay 5, 2026 | $3.6M68.8k shares | $53.00 | -- | |
| $0750k shares | OtherMay 5, 2026 | $2.8M750k shares | $3.73 | -- | |
| $040.5k shares | OtherMay 5, 2026 | $2.1M40.5k shares | $53.00 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $5.1M137.5k shares | Grant / ExerciseJan 14, 2026 | $5.1M137.5k shares | $37.18 | -- | |
| --101.8k shares | Grant / ExerciseJan 14, 2026 | Disclosure amount unavailable68.8k shares | -- | -- | |
| $98k25k shares | BuyJun 27, 2025 | $19.6K5k shares | $3.93 | -- | |
| $79k20k shares | BuyJun 27, 2025 | $19.6K5k shares | $3.93 | -- | |
| $59k15k shares | BuyJun 16, 2025 | $19.7K5k shares | $3.95 | -- | |
| $19k5k shares | BuyJun 13, 2025 | $18.8K5k shares | $3.75 | -- | |
| $37k10k shares | BuyJun 13, 2025 | $18.6K5k shares | $3.72 | -- | |
| $2.8M750k shares | Grant / ExerciseFeb 24, 2025 | $2.8M750k shares | $3.73 | -- | |
| $55k97.5k shares | SellSep 5, 2024 | $7201.3k shares | $0.566 | -- | |
| --98.8k shares | Grant / ExerciseSep 3, 2024 | Disclosure amount unavailable5k shares | -- | -- |